Scholarly Index
Hans‐Peter Brunner‐La Rocca
Maastricht University; 30,390 total citations; 459 total publications; best world rank #112
Maastricht University
30,390Total citations
459Total publications
74H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Heart Failure Treatment and Management | Lifetime | 170 | NL 7 | 99.32 |
| Cardiovascular Function and Risk Factors | Lifetime | 436 | NL 17 | 99.21 |
| Cardiac pacing and defibrillation studies | Lifetime | 371 | NL 17 | 98.86 |
| Potassium and Related Disorders | Lifetime | 127 | NL 8 | 97.46 |
| Cardiovascular and exercise physiology | Lifetime | 665 | NL 16 | 97.33 |
| Medication Adherence and Compliance | Lifetime | 678 | NL 26 | 92.20 |
| GDF15 and Related Biomarkers | Lifetime | 239 | NL 4 | 89.07 |
| Heart rate and cardiovascular health | Lifetime | 703 | NL 27 | 68.44 |
| Heart Failure Treatment and Management | 2021-2025 | 112 | NL 5 | 98.73 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 514 | NL 21 | 96.57 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 436 | NL 20 | 95.26 |
| Potassium and Related Disorders | 2021-2025 | 159 | NL 10 | 86.83 |
| Medication Adherence and Compliance | 2021-2025 | 364 | NL 12 | 82.61 |
| Cardiovascular and exercise physiology | 2021-2025 | 961 | NL 14 | 85.63 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 290 | NL 9 | 76.22 |
| GDF15 and Related Biomarkers | 2021-2025 | 598 | NL 12 | 54.21 |